JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB269506

Human NBN (p95/NBS1) knockout A-431 cell line

Be the first to review this product! Submit a review

|

(0 Publication)

NBN KO cell line available to order. KO validated by Next Generation Sequencing, Western blot. Free of charge wild type control available. Knockout achieved by CRISPR/Cas9; X = 1 bp insertion, 2 bp deletion, 11 bp deletion; Frameshift: 99%. To order both knockout and wild-type control cells: select '2 x 1000000 Cells/vial'. To order only knockout cells: select '1000000 Cells/vial'.
5 Images
Western blot - Human NBN (p95/NBS1) knockout A-431 cell line (AB269506)
  • WB

Lab

Western blot - Human NBN (p95/NBS1) knockout A-431 cell line (AB269506)

False colour image of Western blot : Anti-p95/NBS1 antibody [7E4A2] staining at 1/500 dilution shown in green; Rabbit Anti-GAPDH antibody [EPR16891] (ab181602) loading control staining at 1/20000 dilution shown in red. In Western blot ab181729 was shown to bind specifically to p95/NBS1. A band was observed at 95 kDa in wild-type A431 cell lysates with no signal observed at this size in NBN knockout cell line ab269506 (knockout cell lysate ab269668). To generate this image wild-type and NBN knockout A431 cell lysates were analysed. First samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4°. Blots were washed four times in TBS-T incubated with secondary antibodies for 1 h at room temperature washed again four times then imaged.Secondary antibodies used were Goat anti-Mouse IgG H&L (IRDye® 800CW) preabsorbed (ab216772) and Goat anti-Rabbit IgG H&L (IRDye® 680RD) preabsorbed (ab216777) at 1/20000 dilution.

All lanes:

Western blot - Anti-p95/NBS1 antibody [7E4A2] (<a href='/en-us/products/primary-antibodies/p95-nbs1-antibody-7e4a2-ab181729'>ab181729</a>) at 1/500 dilution

Lane 1:

Wild-type A431 cell lysate at 20 µg

Lane 2:

NBN knockout A431 cell lysate at 20 µg

Lane 2:

Western blot - Human NBN (p95/NBS1) knockout A-431 cell line (ab269506)

Predicted band size: 84 kDa

Observed band size: 95 kDa

false

Western blot - Human NBN (p95/NBS1) knockout A-431 cell line (AB269506)
  • WB

Lab

Western blot - Human NBN (p95/NBS1) knockout A-431 cell line (AB269506)

False colour image of Western blot : Anti-p95/NBS1 antibody [7E4C2] staining at 1/500 dilution shown in green; Rabbit Anti-GAPDH antibody [EPR16891] (ab181602) loading control staining at 1/20000 dilution shown in red. In Western blot ab181780 was shown to bind specifically to p95/NBS1. A band was observed at 95 kDa in wild-type A431 cell lysates with no signal observed at this size in NBN knockout cell line ab269506 (knockout cell lysate ab269668). To generate this image wild-type and NBN knockout A431 cell lysates were analysed. First samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4°. Blots were washed four times in TBS-T incubated with secondary antibodies for 1 h at room temperature washed again four times then imaged.Secondary antibodies used were Goat anti-Mouse IgG H&L (IRDye® 800CW) preabsorbed (ab216772) and Goat anti-Rabbit IgG H&L (IRDye® 680RD) preabsorbed (ab216777) at 1/20000 dilution.

All lanes:

Western blot - Anti-p95/NBS1 antibody [7E4C2] (<a href='/en-us/products/primary-antibodies/p95-nbs1-antibody-7e4c2-ab181780'>ab181780</a>) at 1/500 dilution

Lane 1:

Wild-type A431 cell lysate at 20 µg

Lane 2:

NBN knockout A431 cell lysate at 20 µg

Lane 2:

Western blot - Human NBN (p95/NBS1) knockout A-431 cell line (ab269506)

Predicted band size: 84 kDa

Observed band size: 95 kDa

false

Western blot - Human NBN (p95/NBS1) knockout A-431 cell line (AB269506)
  • WB

Lab

Western blot - Human NBN (p95/NBS1) knockout A-431 cell line (AB269506)

Lanes 1 - 2 : Merged signal (red and green). Green - ab32074 observed at 90 kDa. Red - loading control ab8245 (Mouse anti-GAPDH antibody [6C5]) observed at 37 kDa.

ab32074 was shown to react with p95/NBS1 in wild-type A431 cells in Western blot with loss of signal observed in NBN knockout cell line ab269506 (NBN knockout cell lysate ab269668). Wild-type A431 and NBN knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 5 % milk in TBS-T (0.1 % Tween®) before incubation with ab32074 and ab8245 (Mouse anti-GAPDH antibody [6C5]) overnight at 4 ° at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 h at room temperature before imaging.

Lanes 1 - 2:

Western blot - Anti-p95/NBS1 antibody [Y112] (<a href='/en-us/products/primary-antibodies/p95-nbs1-antibody-y112-ab32074'>ab32074</a>) at 1/1000 dilution

Lanes 1 - 3:

Western blot - Anti-p95/NBS1 antibody (<a href='/en-us/products/primary-antibodies/p95-nbs1-antibody-ab23996'>ab23996</a>) at 1/1000 dilution

Lane 1:

Wild-type A431 cell lysate at 20 µg

Lanes 2 - 3:

NBN knockout A431 cell lysate at 20 µg

Lane 2:

Western blot - Human NBN (p95/NBS1) knockout A-431 cell line (ab269506)

Predicted band size: 84 kDa

Observed band size: 90 kDa,95 kDa

false

Next Generation Sequencing - Human NBN (p95/NBS1) knockout A-431 cell line (AB269506)
  • NGS

Supplier Data

Next Generation Sequencing - Human NBN (p95/NBS1) knockout A-431 cell line (AB269506)

Knockout achieved by CRISPR/Cas9; X = 1 bp insertion, 2 bp deletion, 11 bp deletion; Frameshift : 99%

Next Generation Sequencing - Human NBN (p95/NBS1) knockout A-431 cell line (AB269506)
  • NGS

Supplier Data

Next Generation Sequencing - Human NBN (p95/NBS1) knockout A-431 cell line (AB269506)

1 bp insertion after Tyr15 (allele 1), 11 bp deletion after Pro14 (allele 2), and 2 bp deletion after Tyr15 (allele 3) of the WT protein

Key facts

Cell type

A-431

Species or organism

Human

Tissue

Skin

Form

Liquid

form

Knockout validation

Next Generation Sequencing,Western blot

Mutation description

Knockout achieved by CRISPR/Cas9; X = 1 bp insertion, 2 bp deletion, 11 bp deletion; Frameshift: 99%

Disease

Epidermoid Carcinoma

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "NGS": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Product details

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab269506-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab263975 Human wild-type A-431 cell line", "number":"AB269506-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab269506 Human NBN (p95/NBS1) knockout A-431 cell line", "number":"AB269506-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab269506-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab269506 Human NBN (p95/NBS1) knockout A-431 cell line", "number":"AB269506-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
NBN
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Next Generation Sequencing, Western blot
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The target known as p95/NBS1 also referred to as NBN protein is a critical component in the DNA damage response mechanism. The full molecular weight of the NBS1 protein is approximately 95 kDa. This protein is abundantly expressed in various tissues particularly where there is a higher rate of cell division or repair such as in the thymus and testis. It plays an important role in maintaining the stability of the genome through its involvement in the repair of double-strand breaks.
Biological function summary

The NBS1 protein functions as an essential component of the MRN complex which also includes MRE11 and RAD50 proteins. This complex is fundamental in accurately detecting DNA double-strand breaks and initiating repair processes. Through its actions NBS1 facilitates numerous cellular processes that preserve genomic integrity such as homologous recombination and non-homologous end joining. Its influence in controlling the cell cycle further emphasizes its role in maintaining cellular health.

Pathways

The NBS1 protein engages significantly in the DNA damage response and repair pathways notably impacting the ATM signaling pathway. By interacting with proteins such as ATM kinase NBS1 facilitates the phosphorylation and activation of several downstream effectors necessary for DNA repair and cell cycle checkpoints. The MRN complex also links with the RAD50 protein highlighting its involvement in these pathways.

Mutations in the NBS1 gene are linked to Nijmegen breakage syndrome characterized by sensitivity to radiation immune deficiency and increased cancer risk. Additionally NBS1's role in pathways makes it pertinent to certain cancer pathologies where its malfunction can contribute to genomic instability. The NBN protein through its interaction with ATM and RAD50 assists in understanding its connection with predispositions to these diseases.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 1 US: 1

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com